ImprovedDye-BindingProcedure for DeterminIngMicrogram Quantitiesof ProteinIn CerebrospinalFluid-Once

3. Black M, Mitchell JR, Zimmerman HJ, et al. Isomazid-associated hepatitis in 114 patients. Gastroenterology 69, 289-302 (1975). 4. Riska N. Hepatitis casesin NH-treated groups and in a control group. Bull mt Union Tuberc 51, 203-208 (1976). 5. Gronhagen-Riska C, Hellstrom P-E, Froseth B. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis. Am Rev Respir Die 118, 461466 (1978). 6. Chin L, Sievers ML, Herrier RN, Picchioni AL. Potentiation of pyridoxine by depressants and anticonvulsants in the treatment of acute isoniazid intoxication in dogs. Toxicol AppI Pharmacol 58, 504-509 (1981). 7. Dietrich R, Erwin V. Biogenic aminealdehyde condensation products: Tetrahydroisoquinolines and tryptolines (13-carbolines). Annu Rev Pharmacol Toxicol 20,5580 (1980). 8. Breitmaier E, Voelter W. ‘3C NMR Spectroscopy, Verlag Chemie, New York, NY, 1978, p 200. 9. Smith AEW. Some recently synthesized tuberculostatic 4-substituted oxadiazolones. Arzneim Forsch 16, 1034-1038 (1966). 10. CollinsMA, Nijm WP, BorgeGF, et a!. Dopamine-related tetrahydroisoquinolines: Significant urinary excretion by alcoholics after alcohol consumption. Science 206, 1184-1186 (1979). 11. Medina VA, Tuma DJ, Donohue TM, Sorrell MF. The effects of ascorbic acid on the formation of acetaldehyde-protein adducts. Hepatology 3, 806 (1983).